For example, Golodirsen and Eteplirsen are FDA-approved ASOs used to treat Duchenne muscular dystrophy (DMD), which promote the skipping of an exon in the DMD gene that would otherwise produce an out-of-frame transcript [142]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.